novo nordisk - Search News

News

Novo Nordisk ends Wegovy sales on Hims & Hers

Reuters on MSN · 58m

Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly's Mounjaro

By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Danish drugmaker Novo Nordisk launched its blockbuster weight-loss drug Wegovy in the world's most populous nation, in a move that will challenge rival Eli Lilly's Mounjaro,

Times Now on MSN · 19m

Novo Nordisk Launches Weight-loss Drug Wegovy in India; How Does It Work?

Novo Nordisk has launched Wegovy, a once-weekly weight-loss injection, in India. The drug aims to manage obesity and reduce heart risks amid the country's growing obesity crisis. Wegovy, which has semaglutide,

The Financial Times · 18h

Novo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments

47mon MSN

Novo Nordisk Has Ended Its Wegovy Deal With Hims & Hers: Here's What Investors Need to Know

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ...

7hon MSN

Hims & Hers stock plunges after Novo Nordisk ends its brief partnership

The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its ...

5hon MSN

Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup

The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations ...

Pharmaceutical Technology40m

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

Novo Nordisk has ended a partnership with telehealth company Him & Hers, after launching the collaboration less than two ...

pharmaphorum53m

Novo Nordisk's fling with Hims & Hers ends in a bust-up

In a statement, Novo Nordisk said that it was terminating the collaboration "due to concerns about their illegal mass ...

Novo Nordisk Ends Hims & Hers Collaboration

As such, Novo Nordisk ended its collaboration with Hims & Hers over concerns of illegal mass compounding and deceptive ...

15h

Novo Nordisk ends Wegovy sales on Hims & Hers over "deceptive marketing" Novo Nordisk said it will stop selling Wegovy on ...

21hon MSN

Novo Nordisk shares fall as obesity pipeline faces investor scrutiny

Shares in Novo Nordisk fell as much as 3.5% on Monday after detailed trial data on its experimental obesity drug CagriSema ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results